Indivior says wins fresh hold on Suboxone copy

(Reuters) - Indivior Plc said on Wednesday a U.S. court ruling had put a hold on Indian rival Dr. Reddy's Laboratories launching a generic competitor to the London-listed drugmaker's bestselling opioid addiction treatment.
Indivior said a preliminary injunction against Dr. Reddy's, in connection with Indivior's Suboxone Film, would remain in place.
(Reporting by Arathy S Nair in Bengaluru; Editing by Sai Sachin Ravikumar)
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 12 2018 | 1:04 PM IST
